Inspiring Scientific Discovery
Search hundreds of thousands of products backed by our one-year, replacement or money-back, satisfaction guarantee.
Enter here to see a listing of our current Summer promotions running until the end of September 2022!
Bioss COVID-19 Products
The ultimate goal of Bioss is to improve the health and quality of life of humans and animals. To fight against COVID-19, Bioss has developed antibodies, proteins, and the ELISA kit in support of studies on the novel coronavirus.
Haven't worked with Bioss Antibodies before? Try one of our 20uL trial-sized vials for just $0.01 plus shipping. Click here to view program details and to request your discount code for this promotional pricing.
Bioss Blog: the conversation with sciences
- Anti-PD-1 /PD-L1 Therapy and its Application LimitsThere is no doubt that PD-1 /PD-L1 inhibitors are a true breakthrough in the fight against cancer. With the launch of PD-1/PD-L1 inhibitors, we obtained a deeper understanding of anti-PD-1/PD-L1 therapy and realized that not all cancer patients are suitable for PD-1/PD-L1 inhibitor treatment. Here, we summarized the contraindications of PD-1/PD-L1 inhibitors to help people understand the new therapeutic means.
- What Do You know about Vascular Endothelial Growth Factor in Cancer Diagnosis?Early screening of suspicious or asymptomatic patients is critical to improve the survival rate and prolong the survival time of cancer patients. Given that VEGF begins to be produced in large amounts during the early stage of cell transformation, such as the Tis stage and T1 stage, it is the ideal time window for tumor screening. Accordingly, the diagnosed patients will have the best chance for successful treatment.
- The “Pox” DiseasesYou have probably heard of smallpox and chickenpox, and now monkeypox. They are all called “pox”, which means they are associated with skin rashes. But are they related, and do they have the same etiology?
Bioss Pathway Maps
Diving into a new project? Get up to speed quickly with these cellular and molecular pathway maps. Each one is expertly researched and hand-drawn by our scientific team. Autophagy, Tumor Immunology, MAPK, WNT Signaling, and many others are available to download, print, and share at your convenience.
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications.